REAL-WORLD BORTEZOMIB USAGE PATTERNS AMONG PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

被引：0
|
作者：
Calkins, G. [1 ]
Kohansimeh, J. [1 ]
Krishna, A. [2 ]
Green, R. J. [1 ]
Curtis, M. [1 ]
Lindberg, F. P. [1 ]
Jaskiw, A. [1 ]
Larrabee, K. [1 ]
Terry, M. [1 ]
Feinstein, R. N. [1 ]
Plotkin, L. [1 ]
Palladino, M. L. [1 ]
Nicacio, L. Viana [1 ]
机构：
[1] Flatiron Hlth, New York, NY USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1881
引用
收藏
页码：742 / 742
页数：1
相关论文
共 50 条
  • [41] Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients
    Szilvia Lovas
    Gergely Varga
    Péter Farkas
    Tamás Masszi
    Nikolett Wohner
    Ágnes Bereczki
    Nóra Adamkovich
    Zita Borbényi
    Árpád Szomor
    Hussain Alizadeh
    Erika Szaleczky
    Krisztina Wolf
    Tamás Schneider
    Márk Plander
    Tamás Szendrei
    Ottó Csacsovszki
    Zoltán Csukly
    Péter Rajnics
    Miklós Egyed
    Zsolt Nagy
    László Rejtő
    Árpád Illés
    Gábor Mikala
    László Váróczy
    [J]. International Journal of Hematology, 2019, 110 : 559 - 565
  • [42] Real-World Safety and Efficacy of Teclistamab for Patients with Heavily Pretreated Relapsed-Refractory Multiple Myeloma
    Dima, Danai
    Davis, James A.
    Ahmed, Nausheen
    Sannareddy, Aishwarya
    Shaikh, Hira
    Mahmoudjafari, Zahra
    Khouri, Jack
    Kaur, Gurbakhash
    Strouse, Christopher
    Valent, Jason
    Larry, Anderson D., Jr.
    Anwer, Faiz
    Abdallah, Al-Ola
    Hashmi, Hamza
    [J]. BLOOD, 2023, 142
  • [43] Ixazomib, lenalidomide, and dexamethasone combination in “real-world” clinical practice in patients with relapsed/refractory multiple myeloma
    Juraj Sokol
    Tomas Guman
    Juraj Chudej
    Monika Hlebaskova
    Natalia Stecova
    Lubica Valekova
    Monika Kucerikova
    Jan Stasko
    [J]. Annals of Hematology, 2022, 101 : 81 - 89
  • [44] Daratumumab Monotherapy in Heavily Pretreated Asian Patients With Relapsed and Refractory Multiple Myeloma: A Real-world Experience
    Byun, Ja Min
    Yoon, Sung-Soo
    Koh, Youngil
    Kim, Inho
    Jo, Jaemin
    Park, Hyunkyung
    Lee, Jeong-Ok
    Lee, Jiyun
    [J]. ANTICANCER RESEARCH, 2019, 39 (09) : 5165 - 5170
  • [45] Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma
    Lee, Ji Hyun
    Kim, Sung-Hyun
    Kim, Hye Ryeon
    Min, Chang-Ki
    Lee, Je-Jung
    Shin, Ho-Jin
    Jo, Jae-Cheol
    Lee, Ji Yun
    Moon, Joon Ho
    Kim, Kihyun
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (02) : 225 - 235
  • [46] Belantamab mafodotin for relapsed/refractory multiple myeloma: a real-world observational study update
    Hultcrantz, Malin
    Kleinman, David
    Vij, Ravi
    Escalante, Fernando
    Delforge, Michel
    Kotowsky, Nirali
    Bitetti, Jacopo
    Boytsov, Natalie
    Camadoo-O'Byrne, Leena
    Happ, Lindsey Powers
    Rohman, Mujib
    Germain, Guillaume
    Duh, Mei Sheng
    Laliberte, Francois
    Mahendran, Malena
    Urosevic, Ana
    Lee, Hans
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S185 - S186
  • [47] Teclistamab for Relapsed/Refractory Multiple Myeloma: Real-World Experience in an Early Access Program
    Uttervall, Katarina
    Nahi, Hareth
    Kashif, Muhammad
    Lemonakis, Konstantinos
    Rosengren, Sara
    Brolin, Janaki
    Lund, Johan
    Hansson, Markus
    [J]. BLOOD, 2022, 140 : 12605 - 12606
  • [48] Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
    Meera Mohan
    Jorge Monge
    Nishi Shah
    Danny Luan
    Mark Forsberg
    Vineel Bhatlapenumarthi
    Metodi Balev
    Anannya Patwari
    Heloise Cheruvalath
    Divaya Bhutani
    Sharmilan Thanendrarajan
    Binod Dhakal
    Maurizio Zangari
    Samer Al-Hadidi
    Dennis Cooper
    Suzanne Lentzsch
    Frits van Rhee
    Anita D’Souza
    Aniko Szabo
    Carolina Schinke
    Rajshekhar Chakraborty
    [J]. Blood Cancer Journal, 14
  • [49] Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study
    Mohan, Meera
    Shah, Nishi
    Luan, Danny
    Monge, Jorge
    Forsberg, Mark
    Bhatlapenumarthi, Vineel
    Balev, Metodi
    Patwari, Anannya
    Cheruvalath, Heloise
    Bhutani, Divaya
    Thanendrarajan, Sharmilan
    Dhakal, Binod
    Zangari, Maurizio
    Al Hadidi, Samer
    Cooper, Dennis L.
    Lentzsch, Suzanne
    van Rhee, Frits
    D'Souza, Anita
    Szabo, Aniko
    Schinke, Carolina
    Chakraborty, Rajshekhar
    [J]. BLOOD, 2023, 142
  • [50] Belantamab Mafodotin for Relapsed or Refractory Multiple Myeloma: A Real-World Observational Study Update
    Hultcrantz, Malin
    Kleinman, David
    Vij, Ravi
    Escalante, Fernando
    Delforge, Michel
    Kotowsky, Nirali
    Bitetti, Jacopo
    Boytsov, Natalie
    Camadoo-O'Byrne, Leena
    Happ, Lindsey Powers
    Rohman, Mujib
    Germain, Guillaume
    Duh, Mei Sheng
    Laliberte, Francois
    Mahendran, Malena
    Urosevic, Ana
    Lee, Hans
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S504 - S504
12345